Fig. 3From: Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodiesCumulative probability plots of the changes from baseline at 12 months. a Modified total Sharp score. b Modified Sharp erosion score. c Modified Sharp joint space narrowing scoreBack to article page